Dear Sir or Madam, MRiPT technology marks a significant advance in cancer treatment. In our interview, Prof. Aswin Hoffmann, head of the research group for experimental MR-integrated proton therapy at the Helmholtz-Zentrum Dresden-Rossendorf, explains the challenges and potential benefits of this technology. He emphasizes the importance of real-time MRI imaging for precision in proton therapy and presents possible solutions to technical challenges. Enjoy reading! Tim Plato Editorial team MEDICA-tradefair.com
|